159 related articles for article (PubMed ID: 19617337)
1. Scintigraphic TNM staging of tumors: a proposition.
Oommen R
J Nucl Med; 2009 Aug; 50(8):1386; author reply 1386. PubMed ID: 19617337
[No Abstract] [Full Text] [Related]
2. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
[TBL] [Abstract][Full Text] [Related]
3. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
4. Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?
Avram AM; Fig LM; Frey KA; Gross MD; Wong KK
J Clin Endocrinol Metab; 2013 Mar; 98(3):1163-71. PubMed ID: 23430789
[TBL] [Abstract][Full Text] [Related]
5. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
6. [Solitary hyperfunctioning thyroid gland carcinomas].
Zivaljevic V; Zivic R; Diklic A; Krgovic K; Kalezic N; Vekic B; Stevanovic D; Paunovic I
Zentralbl Chir; 2011 Aug; 136(4):374-8. PubMed ID: 21082544
[TBL] [Abstract][Full Text] [Related]
7. Advances in the medical management of differentiated thyroid carcinoma and their impact on the surgical approach.
Van den Bruel A; Vauterin T; Poorten VV; Decallonne B
Acta Chir Belg; 2007 Jun; 107(3):271-8. PubMed ID: 17685252
[TBL] [Abstract][Full Text] [Related]
8. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
Mirallié E; Guillan T; Bridji B; Resche I; Rousseau C; Ansquer C; Bodet-Milin C; Curtet C; Carnaille B; Murat A; Charbonnel B; Kraeber-Bodéré F
Surgery; 2007 Dec; 142(6):952-8; discussion 952-8. PubMed ID: 18063081
[TBL] [Abstract][Full Text] [Related]
10. [Methodology for evaluation of malignancy screening in surgical thyroid gland disease].
Rubio V; Tamarit JM; Baviera N; Fernández S; Estrems P; Seijas T; López C; Dalmau J
Acta Otorrinolaringol Esp; 2009; 60(6):390-5. PubMed ID: 19850274
[TBL] [Abstract][Full Text] [Related]
11. [Differentiated thyroid cancers].
Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of preoperative DNA measurement on FNA in benign and malignant thyroid neoplasm.
Perigli G; Cicchi P; Cianchi F; Artusi R; Olivari D; Caldini A; Cortesini C
J Exp Clin Cancer Res; 1998 Mar; 17(1):113-6. PubMed ID: 9646245
[No Abstract] [Full Text] [Related]
13. Follicular neoplasms of the thyroid: diagnostic and operative management.
Bernante P; Toniato A; Piotto A; Gemo G; Pagetta C; Bernardi C; Pelizzo MR
J Exp Clin Cancer Res; 1998 Mar; 17(1):125-6. PubMed ID: 9646248
[No Abstract] [Full Text] [Related]
14. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
15. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison.
Finnerty BM; Kleiman DA; Scognamiglio T; Aronova A; Beninato T; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2015 Apr; 22(4):1200-6. PubMed ID: 25297901
[TBL] [Abstract][Full Text] [Related]
16. [Is total thyroidectomy and lymph node excision as therapy of differentiated thyroid gland carcinomas in childhood justified?].
Witte J; Goretzki PE; Simon D; Röher HD
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():196-8. PubMed ID: 9101829
[TBL] [Abstract][Full Text] [Related]
17. [Combination PET/CT with 124I positron rays in metastatic follicular thyroid carcinoma].
Görges R; Antoch G; Brandau W; Freudenberg LS; Knust J; Dutschka K; Müller SP; Jentzen W; Bockisch A; Stattaus J
Nuklearmedizin; 2002 Oct; 41(5):N68-71. PubMed ID: 12418312
[No Abstract] [Full Text] [Related]
18. [Surgical strategies in the diagnosis and treatment of patients with differentiated thyroid cancer].
Lipskaia EV; Romanchishen AF; Kolosiuk VA
Vestn Khir Im I I Grek; 2004; 163(1):11-5. PubMed ID: 15143574
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Lenschow C; Lindner K; Müller AK; Barth P; Senninger N; Colombo-Benkmann M
Chirurg; 2016 Mar; 87(3):247-50. PubMed ID: 26223667
[No Abstract] [Full Text] [Related]
20. Overview of the management of differentiated thyroid cancer.
Fernandes JK; Day TA; Richardson MS; Sharma AK
Curr Treat Options Oncol; 2005 Jan; 6(1):47-57. PubMed ID: 15610714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
